Source: ALL
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.600 | None | 0.965 | 86 | 0 | 1989 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.970 | 101 | 5 | 1992 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 18 | 0 | 2008 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.933 | 15 | 2 | 2000 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 2013 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 1999 | 2015 | ||||||||
|
RAD51 recombinase | 0.447 | 0.846 | 2.7E-02 |
|
disease | 0.360 | None | 1.000 | 6 | 0 | 2006 | 2014 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 1993 | 2019 | ||||||||
|
X-ray repair cross complementing 3 | 0.505 | 0.769 | 1.9E-10 |
|
disease | 0.350 | None | 1.000 | 5 | 2 | 2005 | 2014 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2002 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2004 | 2018 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 1992 | 2009 | ||||||||
|
glutathione peroxidase 1 | 0.458 | 0.923 | 3.9E-05 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2004 | 2017 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2008 | 2017 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.320 | strong | 1.000 | 2 | 0 | 2004 | 2015 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2008 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2010 | ||||||||
|
retinoic acid receptor beta | 0.478 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2004 | 2007 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 1993 | 2001 | ||||||||
|
amphiregulin | 0.487 | 0.769 | 0.35 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2004 | 2009 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2015 | 2018 | ||||||||
|
mal, T cell differentiation protein | 0.570 | 0.577 | 0.83 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
uroporphyrinogen decarboxylase | 0.521 | 0.769 | 1.3E-08 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
FAT atypical cadherin 1 | 0.508 | 0.808 | 1.2E-12 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
signal transducer and activator of transcription 6 | 0.475 | 0.808 | 0.99 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 |